Drug intelligence / Profile preview

Kofarest

Development stage
Unknown
Lead developer
Centaur Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Kofarest is a brand name representing a comprehensive range of cough and cold preparations developed and marketed by Centaur Pharmaceuticals. The Kofarest range includes several distinct formulations tailored for different types of coughs in both adult and pediatric populations. The standard Kofarest Syrup is a fixed-dose combination of the mucolytic ambroxol, the expectorant guaifenesin, and the bronchodilator terbutaline, which is indicated for the treatment of productive cough associated with bronchospasm in conditions such as bronchitis, bronchial asthma, and chronic obstructive pulmonary disease (COPD). Other formulations in the range include Kofarest LS (containing levosalbutamol, ambroxol, and guaifenesin) and Kofarest DX (containing dextromethorphan and chlorpheniramine) to address dry, non-productive coughs.

Brand names
KofarestKofarest BTKofarest DropsKofarest DX LinctusKofarest LD SyrupKofarest LS Junior SyrupKofarest LS SyrupKofarest PD DropsKofarest PD SyrupKofarest Syrup
Other names
Kofarest range
02

Targets

ADRB2 (β2)HRH1 (Histamine H1 Receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)

Beyond the preview

Go deeper on Kofarest.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kofarest.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call